Vaibhav Kumar

757 total citations
25 papers, 311 citations indexed

About

Vaibhav Kumar is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vaibhav Kumar has authored 25 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vaibhav Kumar's work include Venous Thromboembolism Diagnosis and Management (6 papers), Economic and Financial Impacts of Cancer (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Vaibhav Kumar is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Economic and Financial Impacts of Cancer (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Vaibhav Kumar collaborates with scholars based in United States, India and United Kingdom. Vaibhav Kumar's co-authors include Monica Bennett, Robert H. Collins, Zora R. Rogers, Joseph W. Fay, Joshua T. Cohen, David M. Kent, Peter J. Neumann, David van Klaveren, John B. Wong and Djøra I. Soeteman and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Vaibhav Kumar

22 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vaibhav Kumar United States 8 122 100 84 81 33 25 311
Sabarish Ayyappan United States 10 111 0.9× 167 1.7× 48 0.6× 42 0.5× 16 0.5× 44 417
Lisa Y. Law United States 8 97 0.8× 113 1.1× 49 0.6× 20 0.2× 44 1.3× 21 279
Phillip L.R. Nicolson United Kingdom 12 215 1.8× 40 0.4× 32 0.4× 74 0.9× 45 1.4× 32 368
P G Cachia United Kingdom 10 212 1.7× 33 0.3× 45 0.5× 56 0.7× 25 0.8× 21 363
Anastasia Laudisi Italy 9 37 0.3× 103 1.0× 62 0.7× 32 0.4× 42 1.3× 13 343
Beverly A. Schaefer United States 9 137 1.1× 57 0.6× 31 0.4× 19 0.2× 23 0.7× 19 284
Helen F. Barker United Kingdom 9 182 1.5× 138 1.4× 17 0.2× 88 1.1× 25 0.8× 12 340
Déborah Martı́nez-Baños Mexico 10 198 1.6× 54 0.5× 29 0.3× 58 0.7× 17 0.5× 24 316
Andrea Duminuco Italy 11 128 1.0× 42 0.4× 31 0.4× 32 0.4× 14 0.4× 60 344
Gianna Maria D’Elia Italy 13 159 1.3× 128 1.3× 38 0.5× 37 0.5× 8 0.2× 33 357

Countries citing papers authored by Vaibhav Kumar

Since Specialization
Citations

This map shows the geographic impact of Vaibhav Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vaibhav Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vaibhav Kumar more than expected).

Fields of papers citing papers by Vaibhav Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vaibhav Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vaibhav Kumar. The network helps show where Vaibhav Kumar may publish in the future.

Co-authorship network of co-authors of Vaibhav Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Vaibhav Kumar. A scholar is included among the top collaborators of Vaibhav Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vaibhav Kumar. Vaibhav Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piantadosi, Steven, Nancy Campbell, Selina Chow, et al.. (2025). Challenges in Automating Extraction of Real-World Radiographic Images and Adverse Events: Lessons From the ICAREdata Initiative. JCO Clinical Cancer Informatics. 9(9). e2400319–e2400319. 1 indexed citations
2.
Liu, Min‐Qian, et al.. (2024). Towards Effective Long Conversation Generation with Dynamic Topic Tracking and Recommendation. 540–556. 1 indexed citations
3.
Kumar, Vaibhav, et al.. (2024). Numerical and Experimental Investigation on Performance of Thermal Energy Storage Integrated Micro-Cold Storage Unit. Applied Sciences. 14(12). 5166–5166. 5 indexed citations
4.
Casak, Sandra J., Vaibhav Kumar, Chi Song, et al.. (2024). FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer. Clinical Cancer Research. 30(16). 3371–3377. 7 indexed citations
5.
Kumar, Vaibhav, et al.. (2024). Sleep Apnea Detection: From Signal Processing to Deep Learning. 1–8. 1 indexed citations
6.
Kumar, Vaibhav, Nathan D. Montgomery, Hendrik W. van Deventer, & Young E. Whang. (2023). Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report. Journal of Medical Case Reports. 17(1). 220–220. 1 indexed citations
7.
Kumar, Vaibhav, Fenggong Wang, Meng Hu, Paul G. Kluetz, & Liang Zhao. (2023). Landscape Analysis of Generic Availability for Oncologic Drugs. Therapeutic Innovation & Regulatory Science. 57(6). 1279–1286.
8.
Kumar, Vaibhav, Leslie Doros, Sirisha L. Mushti, et al.. (2022). FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor. Clinical Cancer Research. 29(11). 2020–2024. 6 indexed citations
9.
Kuo, Tzy‐Mey, Vaibhav Kumar, Mark Robert Holmes, et al.. (2022). Temporal Changes in Treatment Patterns for Rural and Urban Patients With Early-Stage Non-Small Cell Lung Cancer. North Carolina Medical Journal. 83(4). 294–303. 2 indexed citations
10.
Tschernia, Nicholas, Vaibhav Kumar, Dominic T. Moore, et al.. (2021). Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia. Transplantation and Cellular Therapy. 27(12). 1021.e1–1021.e5. 17 indexed citations
11.
Ilich, Anton, Vaibhav Kumar, Michael J. Ferrara, et al.. (2021). Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma. Thrombosis Research. 204. 22–28. 8 indexed citations
12.
Ilich, Anton, Vaibhav Kumar, Michael W. Henderson, et al.. (2020). Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study. Thrombosis Research. 191. S31–S36. 10 indexed citations
13.
Shaw, Joseph R., Vaibhav Kumar, Ranjeeta Mallick, et al.. (2020). Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer. Thrombosis Research. 196. 437–443. 2 indexed citations
14.
Kumar, Vaibhav, Joseph R. Shaw, Nigel S. Key, et al.. (2020). D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer. The Oncologist. 25(12). 1075–1083. 22 indexed citations
15.
Kumar, Vaibhav, Xi Zhou, Tzy‐Mey Kuo, et al.. (2020). Venous Thromboembolism Incidence and Impact on Survival in Patients with Brain Metastases. Blood. 136(Supplement 1). 1–1. 2 indexed citations
16.
Kumar, Vaibhav, et al.. (2019). Hemophagocytic lymphohistiocytosis in a patient with glioblastoma: a case report. CNS Oncology. 8(4). CNS45–CNS45. 3 indexed citations
17.
Kumar, Vaibhav, Kishwar Ali, Amresh Kumar, et al.. (2018). Cloning and heterologous expression of Os-AP2/ERF-N22 drought inducible rice transcription factor in E. coli. The Indian Journal of Agricultural Sciences. 88(10). 1515–1520. 2 indexed citations
18.
Kumar, Vaibhav, et al.. (2013). Obstructing broncholith. The Lancet. 382(9903). 1534–1534.
19.
Charron, Catherine E., Pai-Chien Chou, Vaibhav Kumar, et al.. (2009). Hypoxia-inducible Factor 1α Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription. Journal of Biological Chemistry. 284(52). 36047–36054. 44 indexed citations
20.
Collins, Robert H., et al.. (1992). Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression.. PubMed. 10(4). 391–5. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabarish Ayyappan Breakdown of academic impact, for papers by Lisa Y. Law Breakdown of academic impact, for papers by Phillip L.R. Nicolson Breakdown of academic impact, for papers by P G Cachia Breakdown of academic impact, for papers by Anastasia Laudisi Breakdown of academic impact, for papers by Beverly A. Schaefer Breakdown of academic impact, for papers by Helen F. Barker Breakdown of academic impact, for papers by Déborah Martı́nez-Baños Breakdown of academic impact, for papers by Andrea Duminuco Breakdown of academic impact, for papers by Gianna Maria D’Elia
Rankless by CCL
2026